All i know is, this quarterly is going to be a good gauge on uptake and future value.
Anything circa $1M+ is a positive to me given their previous sales figures.
With the inclusion of Australia/NZ tail end of winter, full pre season in the US and now this group on board, I would be utterly shocked if it was anything less.
Ann: Lumos Awarded National Contract with MediGroup for FebriDx, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $24.66K | 945.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 315442 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 1463859 | 3 |
View Market Depth
| Last trade - 15.59pm 24/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |